AORT (AORT) investor files to sell 616 shares after 44,001-share sale

Rhea-AI Filing Summary

A holder of AORT common stock filed a notice of intent to sell 616 shares, with an aggregate market value of $17,586.18, through Fidelity Brokerage Services LLC on August 14, 2026 on the NYSE. These shares relate to restricted stock vesting as compensation on August 12, 2026, and follow a prior sale of 44,001 shares for $910,753.51 on June 11, 2026 by Andrew M. Green.

Key Figures

Planned shares to be sold: 616 shares Planned aggregate market value: $17,586.18 Shares from prior sale: 44,001 shares +3 more

6 metrics

Planned shares to be sold 616 shares Common stock to be sold on August 14, 2026

Planned aggregate market value $17,586.18 Aggregate market value of 616 shares of common stock

Shares from prior sale 44,001 shares Common stock sold on June 11, 2026

Value of prior sale $910,753.51 Total consideration for 44,001 shares sold on June 11, 2026

Restricted stock vesting date 08/12/2026 Date of restricted stock vesting related to 616 shares

Broker Fidelity Brokerage Services LLC Broker handling proposed sale of 616 shares

Key Terms

Form 144, restricted stock vesting, aggregate market value

3 terms

Form 144 regulatory

"A holder of AORT common stock filed a notice of intent under Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock vesting financial

"These shares relate to restricted stock vesting as compensation on August 12, 2026"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

aggregate market value financial

"616 shares, with an aggregate market value of $17,586.18"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What stock sale is being planned for AORT in this Form 144?

The filing indicates an intent to sell 616 shares of AORT common stock, with an aggregate market value of $17,586.18, through Fidelity Brokerage Services LLC on August 14, 2026 on the NYSE.

Who is associated with the AORT Form 144 filing and prior sales?

The notice lists Andrew M. Green, located in Kennesaw, Georgia, in connection with prior sales of AORT common stock, including a transaction on June 11, 2026 for 44,001 shares.

What prior AORT stock sales occurred in the last three months?

Within the past three months, a sale of 44,001 shares of AORT common stock for total consideration of $910,753.51 on June 11, 2026 is reported as having occurred.

What is the nature of the AORT shares to be sold under this Form 144?

The planned sale involves AORT common stock that arose from restricted stock vesting as compensation on August 12, 2026, with 616 shares identified for potential sale.

Which broker is handling the planned AORT stock sale?

The transaction is listed with Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, as the broker for the proposed sale of 616 AORT shares on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 03:18 PM Accepted by SEC EDGAR 08/14/2026 - 03:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	616	17586.18	48756221	08/14/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2026	Restricted Stock Vesting	Issuer			616	08/12/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Andrew M. Green 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	06/11/2026	44001	910753.51

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)